Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Debt to Equity (2016 - 2022)

Historic Debt to Equity for Nephros (NEPH) over the last 9 years, with Q4 2022 value amounting to $0.02.

  • Nephros' Debt to Equity fell 1720.53% to $0.02 in Q4 2022 from the same period last year, while for Dec 2022 it was $0.02, marking a year-over-year decrease of 1720.53%. This contributed to the annual value of $0.02 for FY2022, which is 1720.53% down from last year.
  • According to the latest figures from Q4 2022, Nephros' Debt to Equity is $0.02, which was down 1720.53% from $0.01 recorded in Q3 2022.
  • Over the past 5 years, Nephros' Debt to Equity peaked at $0.63 during Q1 2018, and registered a low of $0.01 during Q3 2022.
  • Moreover, its 5-year median value for Debt to Equity was $0.06 (2020), whereas its average is $0.14.
  • As far as peak fluctuations go, Nephros' Debt to Equity plummeted by 9231.1% in 2018, and later soared by 477.73% in 2022.
  • Over the past 5 years, Nephros' Debt to Equity (Quarter) stood at $0.27 in 2018, then plummeted by 43.45% to $0.15 in 2019, then tumbled by 70.07% to $0.05 in 2020, then crashed by 49.06% to $0.02 in 2021, then dropped by 17.21% to $0.02 in 2022.
  • Its Debt to Equity stands at $0.02 for Q4 2022, versus $0.01 for Q3 2022 and $0.03 for Q2 2022.